✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹3,773 Cr.
P/E
27.56

Key Ratios

Market cap
Market cap
3,773 Cr
PE
PE
27.56
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
9.23
ROCE (%)
ROCE (%)
12.68
Div Yield (%)
Div Yield (%)
1.06
Sales
Sales
668 Cr
OPM (%)
OPM (%)
29.88 %
Debt to Equity
Debt to Equity
-
About
Advanced Enzyme is in the Miscellaneous sector with a M.cap of 3773.00 Cr and a PE rat… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Advanced Enzyme Technologies Ltd. Business

Advanced Enzymes Technologies Limited is the largest Indian enzyme company focusing on research, development, and manufacturing of enzymes and probiotics. Their aim is to provide side-effect free healthcare solutions, improve animal nutrition, and promote enzyme-based industrial processes.

Advanced Enzyme major competitors are Fermenta Biotech, Concord Biotech, Biocon, Orchid Pharma, Gufic Biosciences, Zota Health Care, Guj. Themis Biosyn.
Market Cap of Advanced Enzyme is ₹3,789 Crs.
While the median market cap of its peers are ₹3,667 Crs.

Advanced Enzyme seems to be less financially stable compared to its competitors.
Altman Z score of Advanced Enzyme is 14.35 and is ranked 4 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material